Low-Branched-Chain Amino Acid Diet With Immunotherapy for Stage III Melanoma
Part of Cancer, Skin clinical trials.
This trial tests whether a special diet low in certain amino acids (building blocks of protein), combined with an immune-boosting antibody drug, can safely shrink stage III melanoma that has spread to lymph nodes. The goal is to see if this combination works better than standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Confirmed stage III melanoma (cancer spread to at least one lymph node or between skin and lymph nodes) diagnosed by biopsy or cell sampling
- No prior cancer treatments (chemotherapy, radiation, or certain immunotherapy drugs) within the last month
- Good overall health and able to care for yourself most of the day (ECOG score 0 or 1)
- At least one measurable tumor spot visible on scans
- Adequate blood counts and organ function (kidneys, liver, clotting) based on recent lab work
- Age 18–75 years old with life expectancy of 6 months or longer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a high-fiber diet and occasional short-term fasting can help melanoma patients respond better to immunotherapy. It aims to improve treatment outcomes by changing gut health.
This trial tests whether a special prebiotic diet can help your body's bacteria (microbiome) better respond to standard immunotherapy for advanced melanoma that cannot be removed by surgery. If you are starting your first immunotherapy, you may be able to join.
This early trial tests CBL0137 along with ipilimumab and nivolumab (two immune-based cancer medicines) in people with stage III or possibly stage IV melanoma that can be biopsied. It may help shrink melanoma and improve immune control, while also learning how safe and effective this combination is.
This trial studies whether eating a high-fiber diet can improve how well immunotherapy works against melanoma by affecting gut bacteria. If you have melanoma and are starting or have recently started immunotherapy, this study may be relevant.
This study tests whether a change in diet can help people with early-stage melanoma or lung cancer who are receiving immunotherapy (a type of treatment that helps your immune system fight cancer). You will be asked to follow a diet, give blood and stool samples, and complete questionnaires to see how the diet affects your body and treatment.
This trial tests if injecting two immunotherapy drugs (ipilimumab and nivolumab) just under the skin can help prevent high-risk stage II melanoma from spreading. It is for people who have recently had a thick melanoma removed and have not yet had a sentinel node biopsy.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.